Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
Holzgreve A, Nitschmann A, Maier SH, Büttner M, Schönecker S, Marschner SN, Fleischmann DF, Corradini S, Belka C, la Fougère C, Bodensohn R, Albert NL, Niyazi M. Holzgreve A, et al. Among authors: la fougere c. Radiother Oncol. 2024 Sep;198:110386. doi: 10.1016/j.radonc.2024.110386. Epub 2024 Jun 14. Radiother Oncol. 2024. PMID: 38880414 Free article. Review.
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology.
Wegen S, Nestle U, Zamboglou C, Spohn SKB, Nicolay NH, Unterrainer LM, Koerber SA, La Fougère C, Fokas E, Kobe C, Eze C, Grosu AL, Fendler WP, Holzgreve A, Werner R, Schmidt-Hegemann NS. Wegen S, et al. Among authors: la fougere c. Strahlenther Onkol. 2024 Nov;200(11):931-941. doi: 10.1007/s00066-024-02260-4. Epub 2024 Aug 9. Strahlenther Onkol. 2024. PMID: 39120747 Free PMC article.
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Kafka M, Horninger A, di Santo G, Virgolini I, Neuwirt H, Unterrainer LM, Kunte SC, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Einspieler H, Shariat SF, Rajwa P, Dozauer R, Tsaur I, Medlock E, Rölz N, Rausch S, la Fougère C, Trautwein N, Roesch MC, Merseburger AS, Zattoni F, Sepulcri M, Ladurner M, Bektic J, Gandaglia G, Horninger W, Heidegger I. Kafka M, et al. Among authors: la fougere c. Eur Urol Oncol. 2024 Jun;7(3):421-429. doi: 10.1016/j.euo.2023.07.018. Epub 2023 Aug 19. Eur Urol Oncol. 2024. PMID: 37604763 Free article.
177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior 223Ra (RALU Study).
Rahbar K, Essler M, Eiber M, la Fougère C, Prasad V, Fendler WP, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Pabst KM, Kurtinecz M, Schmall A, Verholen F, Sartor O. Rahbar K, et al. Among authors: la fougere c. J Nucl Med. 2023 Dec 1;64(12):1925-1931. doi: 10.2967/jnumed.123.266125. J Nucl Med. 2023. PMID: 37827838 Free PMC article.
Non-invasive estimation of split renal function from routine 68Ga-SSR-PET/CT scans.
Weissinger M, Seyfried KC, Ursprung S, Castaneda-Vega S, Seith F, von Beschwitz S, Vogel J, Ghibes P, Nikolaou K, la Fougère C, Dittmann H. Weissinger M, et al. Among authors: la fougere c. Front Med (Lausanne). 2023 Jun 28;10:1169451. doi: 10.3389/fmed.2023.1169451. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37448797 Free PMC article.
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.
Hinterleitner M, Pfeiffer R, Trautwein NF, Sipos B, Singer S, Nadalin S, Königsrainer A, Lauer UM, la Fougère C, Zender L, Hinterleitner C. Hinterleitner M, et al. Among authors: la fougere c. Front Endocrinol (Lausanne). 2024 Jan 8;14:1285529. doi: 10.3389/fendo.2023.1285529. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260136 Free PMC article.
Safety and Efficacy of 177Lu-PSMA Therapy Following 223Radium Treatment: A Retrospective Multinational Real-World Analysis.
Giannini G, Kafka M, Neuwirt H, Artamonova N, Santo GD, Virgolini I, Dotzauer R, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Tsaur I, Rausch S, Einspieler H, la Fougère C, Trautwein NF, Zattoni F, Sepulcri M, Heidegger I. Giannini G, et al. Among authors: la fougere c. Clin Genitourin Cancer. 2024 Nov 1;23(1):102260. doi: 10.1016/j.clgc.2024.102260. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39608079
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease.
Hofmann A, Häsler LM, Lambert M, Kaeser SA, Gräber-Sultan S, Obermüller U, Kuder-Buletta E, la Fougere C, Laske C, Vöglein J, Levin J, Fox NC, Ryan NS, Zetterberg H, Llibre-Guerra JJ, Perrin RJ, Ibanez L, Schofield PR, Brooks WS, Day GS, Farlow MR, Allegri RF, Chrem Mendez P, Ikeuchi T, Kasuga K, Lee JH, Roh JH, Mori H, Lopera F, Bateman RJ, McDade E, Gordon BA, Chhatwal JP, Jucker M, Schultz SA; Dominantly Inherited Alzheimer Network. Hofmann A, et al. Among authors: la fougere c. Nat Commun. 2024 Nov 18;15(1):9982. doi: 10.1038/s41467-024-52937-8. Nat Commun. 2024. PMID: 39557867 Free PMC article.
258 results